Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells

The Journal of Clinical Investigation
B N CronsteinR Hirschhorn

Abstract

Since adenosine and its analogue 2-chloroadenosine prevent neutrophils from generating superoxide anion in response to chemoattractants, we sought to determine whether these agents could inhibit neutrophil-mediated injury of endothelial cells. The chemoattractant N-formyl-methionyl-leucyl-phenylalanine (FMLP, 0.1 microM) enhanced the adherence of neutrophils to endothelial cells twofold (18 +/- 2% vs. 39 +/- 3% adherence, P less than 0.001) and caused substantial neutrophil-mediated injury to endothelial cells (2 +/- 2% vs. 39 +/- 4% cytotoxicity, P less than 0.001). 2-Chloroadenosine (10 microM) not only inhibited the adherence of stimulated neutrophils by 60% (24 +/- 2% adherence, P less than 0.001) but also diminished the cytotoxicity by 51% (20 +/- 4% cytotoxicity, P less than 0.002). Furthermore, depletion of endogenously released adenosine from the medium by adenosine deaminase-enhanced injury to endothelial cells by stimulated neutrophils (from 39 +/- 4% to 69 +/- 3% cytotoxicity, P less than 0.001). Indeed, in the presence of adenosine deaminase, even unstimulated neutrophils injured endothelial cells (19 +/- 4% vs. 2 +/- 2% cytotoxicity, P less than 0.001). These data indicate that engagement of adenosine receptors pre...Continue Reading

References

Jan 1, 1979·The American Journal of Cardiology·A C FoxB B Silk
Apr 1, 1985·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·C T BishopB A Freeman
Aug 1, 1985·The Journal of Clinical Investigation·J FehrP Groscurth
May 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·B T WaltherS Roseman
May 1, 1974·The Journal of Clinical Investigation·A C FoxB B Silk
Sep 1, 1981·The Journal of Clinical Investigation·S J WeissN F Nimeh
Oct 1, 1983·The Journal of Experimental Medicine·B N CronsteinR Hirschhorn
Feb 1, 1984·The Journal of Experimental Medicine·A Ager, J L Gordon
Nov 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·M A BoogaertsC F Moldow
Dec 1, 1981·The Journal of Clinical Investigation·J M HarlanD G Wright

❮ Previous
Next ❯

Citations

Oct 19, 1999·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·G P HannaR W Smalling
Sep 6, 2000·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·A R AssaliO R Rosales
Dec 7, 2000·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·S SdringolaR W Smalling
Dec 1, 1996·Arthritis and Rheumatism·B N Cronstein
Aug 1, 1992·Naunyn-Schmiedeberg's Archives of Pharmacology·D NolteK Messmer
Oct 1, 1992·Inflammation·B N Cronstein
Nov 30, 2000·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·M KasaharaY Kaneko
Sep 14, 1999·Heart and Vessels·M Kitakaze, M Hori
Mar 29, 2005·Basic Research in Cardiology·J Vinten-JohansenF Kerendi
Dec 2, 2009·Modern Rheumatology·Edwin S L Chan, Bruce N Cronstein
Sep 1, 1994·The Annals of Thoracic Surgery·D A HudspethD G Van Wylen
Sep 1, 1995·The Annals of Thoracic Surgery·J Vinten-JohansenH Sato
Nov 27, 1995·Biochemical Pharmacology·C R BarnesG W Sullivan
Oct 29, 1991·European Journal of Pharmacology·H H OeiA Y Jeng
Jul 15, 1992·Mechanisms of Ageing and Development·M H Perskin, B N Cronstein
Nov 1, 1995·Immunopharmacology·G W SullivanG L Mandell
Jan 1, 1989·Pharmacology & Therapeutics·J L Grem, P H Fischer
Mar 1, 1989·Brain Research Bulletin·J W Phillis, M H O'Regan
Feb 1, 1989·Journal of the American College of Cardiology·M B FormanR Virmani
Apr 6, 2004·Atherosclerosis·Phoebe A RechtRichard I Levin
Jun 19, 1997·The American Journal of Cardiology·C B Granger
Dec 10, 1999·The Annals of Thoracic Surgery·J Vinten-JohansenR A Guyton
Mar 19, 1997·European Journal of Pharmacology·M A KurzM A Young
Feb 13, 1999·European Journal of Pharmacology·D K Von Lubitz
Jun 4, 1999·European Journal of Pharmacology·D K von Lubitz
Dec 29, 1998·Transplantation Proceedings·S Massberg, K Messmer
Sep 30, 2000·Brain Research. Brain Research Reviews·A de MendonçaJ A Ribeiro
Jun 28, 2000·Journal of the Autonomic Nervous System·G R Dubyak
Jan 17, 2004·Journal of the American Academy of Dermatology·Frank C Saporito, M Alan Menter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.